发明名称 |
T cell receptor-deficient T cell compositions |
摘要 |
The invention is directed to modified T cells, methods of making and using isolated, modified T cells, and methods of using these isolated, modified T cells to address diseases and disorders. In one embodiment, this invention broadly relates to TCR-deficient T cells, isolated populations thereof, and compositions comprising the same. In another embodiment of the invention, these TCR-deficient T cells are designed to express a functional non-TCR receptor. The invention also pertains to methods of making said TCR-deficient T cells, and methods of reducing or ameliorating, or preventing or treating, diseases and disorders using said TCR-deficient T cells, populations thereof, or compositions comprising the same. |
申请公布号 |
US9028812(B2) |
申请公布日期 |
2015.05.12 |
申请号 |
US201013502978 |
申请日期 |
2010.10.29 |
申请人 |
The Trustees of Dartmouth College |
发明人 |
Sentman Charles L. |
分类号 |
C12N5/10;C12N5/0783;A61K39/00 |
主分类号 |
C12N5/10 |
代理机构 |
LeClair Ryan, a professional corporation |
代理人 |
LeClair Ryan, a professional corporation ;Teskin Robin L. |
主权项 |
1. An isolated TCR-deficient T cell that does not express a functional TCR, wherein said T cell further expresses at least one functional exogenous non-TCR receptor which comprises a chimeric receptor comprising a ligand binding domain attached to a signaling domain. |
地址 |
Hanover NH US |